Comparison of original and modified Q risk 2 risk score with Framingham risk score - An Indian perspective.

Aggarwal, Puneet; Sinha, Santosh Kumar; Khanra, Dibbendhu; Nath, Ranjit Kumar; Gujral, Jaskaran; Reddy, Kranthi Kumar; Mukherjee, Anindya

Aggarwal, Puneet; Sinha, Santosh Kumar; Khanra, Dibbendhu; Nath, Ranjit Kumar; Gujral, Jaskaran; Reddy, Kranthi Kumar; Mukherjee, Anindya.

Afiliación

Aggarwal P; ABVIMS and Dr RML Hospital, New Delhi, India. Electronic address: puneetaggarwal4u@gmail.com.
Sinha SK; LPS Institute of Cardiology, Kanpur, India. Electronic address: fionasan@rediffmail.com.
Khanra D; AIIMS, Rishikesh, India. Electronic address: ddk3987@gmail.com.
Nath RK; ABVIMS and Dr RML Hospital, New Delhi, India. Electronic address: rajitknath@yahoo.com.
Gujral J; ABVIMS and Dr RML Hospital, New Delhi, India. Electronic address: jaskarangujral@gmail.com.
Reddy KK; AIIMS, Rishikesh, India. Electronic address: kranthi1237@gmail.com.
Mukherjee A; Department of Cardiology, NRS Medical College, Kolkata, India. Electronic address: anindya768@yahoo.co.in.

Indian Heart J ; 73(3): 353-358, 2021.

Article en En | MEDLINE | ID: mdl-34154755

Asunto(s)

Enfermedades Cardiovasculares; Enfermedades Cardiovasculares/epidemiología; Enfermedades Cardiovasculares/prevención & control; Humanos; Prevalencia; Medición de Riesgo; Factores de Riesgo

Palabras clave

Cardiovascular disease; Framingham risk score; Primary prevention; Q risk 2; Smokeless tobacco

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google